74852-90-7Relevant academic research and scientific papers
4-[4-[4-(4-HYDROXYPHENYL)-l-PIPERAZINYL]-PHENYL]-5-METHYL-3H-1,2,4-TRIAZOL-3-ONE DERIVATIVES
-
, (2008/06/13)
2-[2-(4-chlorophenyl)-2-(hydroxy or oxo)ethyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1 -piperazinyl]-phenyl]-5-methyl-3H-l,2,4-triazol-3-one having the formula wherein X represents C= 0 or CHOH, for use as 5-lipoxygenase inhibitors. Pharmaceutical compositions, processes for preparing said compounds and compositions; and a method of treating leukotriene mediated diseases
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones
Heeres,Backx,Van Cutsem
, p. 894 - 900 (2007/10/02)
A series of novel triazol-3-ones has been synthesized, and their in vitro and in vivo antifungal properties are reported. Traconazole. which displays a pronounced oral activity against vaginal candidosis in rats and against microsporosis in guinea pigs, has been selected for clinical evaluation.
Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
-
, (2008/06/13)
Novel heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles, useful as antifungal and antibacterial agents.
